Table 1. Diabetes medications in IDL in 2017 .
| Medicine Group | Medicine Name | Medicine Price a | ATC Code | Dosage Form |
| Alpha glucosidase inhibitor | Acarbose | 2500 | A10BF01 | 2 |
| Biguanide | Metformin | 900 | A10BA02 | 5 |
| Biguanide + sulfonylurea/thiazolidinedione/dipeptidyl peptidase-4 inhibitor | Metformin + glibenclamide | 1200 | A10BD02 | 5 |
| Metformin + pioglitazone | 5000 | A10BD05 | ||
| Metformin + sitagliptin | 12 300 | A10BD07 | ||
| Dipeptidyl peptidase-4 inhibitor | Linagliptin | - | A10BH05 | 1 |
| Dipeptidyl peptidase-4 inhibitor | Sitagliptin | 10 000 | A10BH01 | 3 |
| Glucagon-like peptide-1 receptor agonist | Exenatide | - | A10BX04 | 2 |
| Liraglutide | 1 850 000 | A10BX07 | ||
| Insulin | Insulin (regular) | 140 000 | A10AB01 | 11 |
| Insulin aspart | 295 000 | A10AB05 | ||
| Insulin biphasic isophane | 72 000 | A10AB06 | ||
| Insulin detemir | 355 000 | A10AB30 | ||
| Insulin glulisin | 235 000 | A10AE01 | ||
| Insulin isophane | 72 000 | A10AE04 | ||
| Insulin zinc | - | A10AE05 | ||
| Meglitinides | Repaglinide | 650 | A10BX02 | 3 |
| Sulfonylureas | Chlorpropamide | 65 | A10BB01 | 5 |
| Glibenclamide | 370 | A10BB02 | ||
| Gliclazide | 1100 | A10BB09 | ||
| Thiazolidinedione | Pioglitazone | 3500 | A10BG03 | 3 |
Abbreviations: IDL, Iran Drug List; ATC, Anatomical Therapeutic Chemical.
a The price is the least price of generic medicine based on the local currency (Iranian Rial). The health insurance organization usually uses this price as the reference for reimbursement.